Yeda Research and Development Company Ltd.

Prof. Mudi Sheves, Chairman

Mr. Amir Naiberg, CEO

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science (WIS). Yeda initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by WIS scientists. Yeda holds an exclusive agreement with the Weizmann Institute to market and commercialize its intellectual property and generate income to support further research and education.

Yeda performs the following activities

Yeda Statistics for 2009-2010

Spanning the Natural Sciences

WIS research and technologies cover a broad spectrum of the natural sciences, including:

Weizmann Scientists

Yeda controls an internal Yeda CEO Fund. This fund aims to support projects that are close to commercialization and due to their practical nature can not be funded by regular scientific research grants. More information is available on our website.

Contact us! We are interested in receiving your patent disclosures, requests, feedback & comments.

Seeking Additional Partners

Yeda partnered with many multinational entities such as Merck- Serono, Novartis, Baxter, Pfizer, Sanofi-Aventis, Johnson & Johnson, Teva, Invitrogen & others. We are actively seeking additional commercial partners and entrepreneurs that can bring WIS technologies to the marketplace.

Additional information on the business opportunities offered by Yeda, can be found at:

http://www.YedaRnD.com
Tel: 972 (0) 8 947 0617
Fax: 972 (0) 8 947 0739
SMS: 972 (0) 8 9366874
e-mail: info.yeda@weizmann.ac.il